Belocura, Pedro, JR.. T.

HRN: 22-07-74  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2022
CEFTRIAXONE 1G (VIAL)
10/21/2022
10/27/2022
IVTT
2g LD; 1g OD
Q24
Cholangitis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Dose  Wrong Dose

Overall appropriateness: No  Wrong Dose

Intervention



Type of Intervention done:

                    

           


Acceptance: